Bleed treatment with eptacog beta rFVIIa results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors

A DunnY Dargaudy AbajasM CarcaoE et alJohnny Mahlangu2025-08-26WOS1351-8216https://hdl.handle.net/10539/46069Bleed treatment with eptacog beta rFVIIa results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitorsJournal Article